The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

A well-known US science journal focused on environmental health has stopped accepting new studies, raising alarms among researchers who rely on it heavily.

Daily variation in continuous glucose monitoring metrics was associated with cognitive performance among patients with type 1 diabetes.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Dr Marty Makary opened up about his first weeks on the job as FDA commissioner and his vision for the future of the agency.

In a sudden about-face, HHS said it won't slash funding for the Women's Health Initiative, a major research project focused on preventing disease in older women.

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.

Florida state lawmakers have approved a bill to ban the addition of fluoride to public drinking water, which could harm dental health.

Brown, MD, and Victoria Francois, MPH, discuss strategies to address the gap in sleep inequalities affecting Black women.

Short sleep duration and regular or occasional snoring are associated with a higher risk for type 2 diabetes in women with gestational diabetes.

US Health and Human Services Secretary Robert F Kennedy Jr is preparing to launch a multimillion-dollar public health campaign.